A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.

@article{Nogueira2006ARR,
  title={A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.},
  author={Paulo Afonso Nogueira and Fabiana Piovesan Alves and Carmen Fern{\'a}ndez-Becerra and Oliver Pein and Neida Rodrigues Santos and Luiz Hildebrando Pereira da Silva and Erney Plessman Camargo and Hernando A Del Portillo},
  journal={Infection and immunity},
  year={2006},
  volume={74 5},
  pages={
          2726-33
        }
}
Progress towards the development of a malaria vaccine against Plasmodium vivax, the most widely distributed human malaria parasite, will require a better understanding of the immune responses that confer clinical protection to patients in regions where malaria is endemic. The occurrence of clinical protection in P. vivax malaria in Brazil was first reported among residents of the riverine community of Portuchuelo, in Rondônia, western Amazon. We thus analyzed immune sera from this same human… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 35 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 38 REFERENCES

Similar Papers

Loading similar papers…